Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 102,766

Document Document Title
WO/2018/201154A1
The disclosure concerns vaccines; and more particularly, highly antigenic thermostable vaccines configured for mucosal or transdermal delivery without reconstitution. Also disclosed are methods for formulating the highly antigenic thermo...  
WO/2018/198817A1
The present invention addresses the problem of providing FcRn having improved stability with respect to heat and acids, a method for producing said FcRn, an antibody adsorbent in which said FcRn is used, and an antibody isolation method ...  
WO/2018/195603A1
The present disclosure relates to bacterial inoculants, and methods for their use, to control a fungal root disease in a plant and promote plant growth in water limited conditions. In particular strains of Paenibacillus and Streptomyces ...  
WO/2018/199113A1
Provided is a method for easily collecting mycoplasma without using cells. This collection method for mycoplasma is characterized by collecting an aggregate which is obtained by further adding a protein, preferably, a water-insoluble car...  
WO/2018/200653A1
The inventors report here combining the use of CRISPR technology with the yeast two-hybrid protein-protein interaction system in order to create a highly advantageous, facile method for investigating RNA-protein interactions and roles of...  
WO/2018/200826A1
The present invention relates to diacylglycerol acyltransferase genes and proteins, and methods of their use. In particular, the invention describes genes encoding proteins having increased diacylglycerol acetyltransferase activity compa...  
WO/2018/199723A2
The present invention relates to novel microalgae having resistance to selenium and a culturing method thereof. More particularly, the present invention can produce selenium-containing cultures in large quantities by using the microalgae.  
WO/2018/197495A1
The invention relates to anti-CRISPR genes and anti-CRISPR proteins, and their uses in various biotechnology applications.  
WO/2018/197621A1
In a first aspect, the present invention relates to a mutated Salmonella strain comprising mutations in flagellin II genes, like the fliF gene, in particular, in addition the aroA gene, the IpxR gene, the pagP gene, the pagL gene, the yd...  
WO/2018/200811A1
The present invention discloses processes for obtaining a color from an algal biomass. The process includes subjecting an algal biomass to cavitation, thus at least partially disrupting cells of the algal biomass and extracting color fro...  
WO/2018/200419A1
Provided herein is an artificial AAV capsid for delivery of an AAV vector genome carrying a transgene with an improved translatability among species. The artificial AAV capsid is also useful in generation of recombinant AAV comprising th...  
WO/2018/200684A1
The invention is directed to kits, compositions, tools and methods for biologically cemented structures. More particularly, the invention is directed to materials and methods for the farming of bivalves, such as oysters and clams, and al...  
WO/2018/199111A1
The purpose of the present invention is to provide: a microorganism which enables the production of muconic acid with good economic efficiency and high yield; and a method for producing muconic acid utilizing the microorganism. The purpo...  
WO/2018/198543A1
The present invention pertains to a reaction mixture for cell-free protein synthesis, said reaction mixture including a cell extract and inosinic acid. The present invention also pertains to a cell-free protein synthesis method in which ...  
WO/2018/199112A1
The purpose of the present invention is to provide: a microorganism which enables the production of muconic acid with good economic efficiency and high yield using a syringyllignin-rich biomass as a raw material; and a method for produci...  
WO/2018/201153A1
Targeted disruption of a specific gene and its subsequent restoration in obligate intracellular bacteria remains extremely challenging due to their absolute requirement for residence inside a host cell to replicate. Here, targeted alleli...  
WO/2018/198542A1
The present invention pertains to a reaction mixture for cell-free protein synthesis, said reaction mixture including a cell extract obtained from Escherichia coli and glycerol. The present invention also pertains to a cell-free protein ...  
WO/2018/201161A1
The present disclosure is generally directed to an anucleated cell-based platforms for encapsulation and delivery of agricultural compounds. Disclosed herein are compositions for the stable and targeted delivery of agricultural compounds...  
WO/2018/193949A1
The present invention addresses the problem of providing a method for efficiently producing dopaminergic neurons within a short period of time. Dopaminergic neurons are produced by a method comprising: (1) a step for culturing pluripoten...  
WO/2018/194889A1
Embodiments of the disclosure encompass methods of treating or preventing an autoimmune disease in an individual. In particular cases, methods comprise administering for delivery to an individual a composition of microbiota. In certain c...  
WO/2018/192507A1
Provided are a Pseudomonas protegens mutant strain Pf5-NiF, Pf5-ΔretS, or Pf5-ΔretS-NiF, and a screening method therefor and an application thereof. By means of Red/ET recombination and direct cloning technologies, NiF nitrogen fixatio...  
WO/2018/192572A1
Provided are a microorganism, an application thereof, and a method for obtaining lycopene using the microorganism. Overexpression of the microorganism comprises at least one selected from genes including tHMG1, BtCarG, PaCrtB, McCrtI, IN...  
WO/2018/193719A1
This cell transfer device is provided with: a head array provided with multiple heads wherein is installed a chip for drawing up and discharging cells and which are able to move in a first direction; a head unit whereto the head array is...  
WO/2018/194092A1
Provided is exo-β-1,2-glucanase which is one member selected from among: exo-β-1,2-glucanase acting on linear β-1,2-glucan to form sophorose; (a) a protein comprising the amino acid sequence of SEQ ID NO: 1; (b) a protein comprising a...  
WO/2018/195467A1
The present disclosure relates to novel lantibiotics, lantibiotic pharmaceutical compositions, isolated and recombinant lantibiotic-producing bacteria, bacterial pharmaceutical compositions, methods of producing novel lantibiotics from l...  
WO/2018/195136A1
The present invention provides compositions and methods for regulated gene expression. In certain aspects, the invention relates to an inducible synthetic promoter that can be used for regulated gene expression or to generate mutations i...  
WO/2018/193273A1
The invention provides novel analogues of enacyloxin Ha and their pharmaceutically acceptable salts, metabolites, isomers (e.g. stereoisomers) and prodrugs. Such compounds are effective in the treatment of infections caused by Gram-negat...  
WO/2018/192059A1
A method for culturing microalgae using a paper-based culture device. The method comprises: 1) designing the shape of a culture device to be a rectangle with circles distributed in the middle; 2) performing wax jet printing on the filter...  
WO/2018/192501A1
A microbial agent containing selenium-rich bifidobacteria, which is used for prevention and/or treatment of intestinal mucosal injury caused by chemotherapy, adjuvant treatment of tumors, mitigation of side effects of tumor chemotherapy,...  
WO/2018/189247A1
The invention relates to newly characterized light-inducible inward proton pumps and their use in medicine, their utility as optogenetic tools, nucleic acid constructs encoding same, expression vectors carrying the nucleic acid construct...  
WO/2018/191636A1
High-throughput column arrays of vascularized living parenchyma / tissue having pillars dispersed in specialized configurations and arrangements substantially vertically through the column to provide support, passive or active perfusion,...  
WO/2018/188617A1
Provided is a method for construction of recombinant bacteria for producing 3-hydroxy propionic acid. The method comprises: knocking out fadR, fabF and fabH genes of receptor bacteria, introducing acc genes or gene clusters, alKL and Mcr...  
WO/2018/188546A1
Disclosed is the use of Isaria cicadae Miquel in the preparation of a drug or health care product with a hypolipidemic/hypoglycemic effect, wherein the Isaria cicadae Miquel alone or in combination with an edible and medicinal traditiona...  
WO/2018/191206A1
A composition composed of xylooligosaccharide, arabinogalactan, inulin, Ganoderma lucidum beta glucan, insoluble yeast β (1, 3/1, 6) -glucan, soluble oat β (1,3/1, 4)- glucan, and insoluble dried Saccharomyces cerevisiae fermentate, wi...  
WO/2018/190398A1
According to the present invention, it becomes possible to produce theanine with high efficiency without requiring adding ethylamine from the outside and without accumulating or remaining ethylamine as a by-product, by using a microorgan...  
WO/2018/190170A1
A method for improving the resistance to a nitrate substrate analogue in a microalga, comprising deleting a gene that encodes a protein (A) or (B) as mentioned below and is located on the genome of a microalga or suppressing the expressi...  
WO/2018/187840A1
The present invention relates to cell culture and the use of nanorods comprising a plasmonic metamaterial for facilitating detachment of cells from the cell culture. These substrates are optically responsive and capable of stimulating pl...  
WO/2018/190407A1
The purpose of the present invention is to provide a novel composition for activating a Toll-like receptor 2. The present invention provides a composition for activating a Toll-like receptor 2 (TLR2) that includes bacteria belonging to B...  
WO/2018/190378A1
The purpose of the present invention is to provide a protein, said protein having an activity of synthesizing rhamnose from glucose, and a polynucleotide encoding the same. Provided are a rhamnose synthase derived from stevia and a metho...  
WO/2018/190772A1
Disclosed herein is a bacterial formulation that includes a bacteria selected from the genus Bacillus and a porous substrate material, wherein the bacteria is supported on and/or within the substrate material. Also disclosed herein are u...  
WO/2018/187381A2
A transkingdom platform for the delivery of therapeutic nucleic acids to epithelial tissues where the nucleic acids are designed to have enhanced stability. The platform offers numerous improvements to prior delivery platforms including ...  
WO/2018/186316A1
[Problem] To provide a bacterial plant disease control agent which has a stable plant disease control effect at real crop production sites and which can be safely used as a biological pesticide. [Solution] By using in combination, as act...  
WO/2018/186487A1
Provided is adenosine as a substance that induces attracting behavior and food searching behavior of fish. Also provided is a novel adenosine receptor as a receptor for adenosine.  
WO/2018/184188A1
Provided are a live recombinant Mycobacterium bovis-BCG strain and a tuberculosis (TB) vaccine or immunogenic composition comprising a nucleic acid capable of overexpression, the nucleic acid encoding PhoP and PhoR proteins. A method for...  
WO/2018/185139A1
A strain of Pseudomonas putidaand its use in the control of diseases caused by fungiand bacteriain plants. The present invention refers to the strain CECT8538 of Pseudomonas putida and mutants thereof, and the use of said strain as a pes...  
WO/2018/187345A1
Provided herein are agricultural compositions, kits, and methods for improving crop productivity and enhancing plant phenotypes. Generally, the compositions and kits comprise an osmoprotectant and one or both of an anti-desiccant and an ...  
WO/2018/186710A1
The present invention relates to a novel strain having the activity of reducing advanced glycation end products and a use thereof and, more particularly, to a Lactococcus lactis KF140(accession number KCCM11673P) strain, a Bacillus subti...  
WO/2018/186312A1
[Problem] To provide a new strain not pathogenic to plants which exhibits a stable bacterial plant disease control effect at real crop production sites and which can be safely used as a biological pesticide, and to provide a bacterial pl...  
WO/2018/185324A1
The present invention relates to a new use of a bacterial secretome in the treatment of skin lesions and more particularly in wound healing. The invention also relates to cosmetic or dermatological compositions comprising such a bacteria...  
WO/2018/185222A1
The present invention relates to polynucleotides capable of catalyzing the aminoacylation of its cognate tRNA with aromatic or aliphatic amino acids to form an aminoacyl-tRNA, polypeptides encoded by such polynucleotides, vectors compris...  

Matches 101 - 150 out of 102,766